Markus Zuber Selected Research

iso-sulfan blue (Lymphazurin)

1/2017	Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial.
10/2015	Intranodal Mapping Using Carbon Dye Results in More Accurate Lymph Node Staging in Colon Cancer Patients.
4/2013	Factors influencing the success of in vivo sentinel lymph node procedure in colon cancer patients: Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer.
12/2003	Identification of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus Zuber Research Topics

Disease

14	Neoplasms (Cancer) 10/2019 - 12/2002
11	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2002
10	Colonic Neoplasms (Colon Cancer) 01/2021 - 12/2003
4	Neoplasm Metastasis (Metastasis) 01/2017 - 05/2011
3	Colorectal Neoplasms (Colorectal Cancer) 06/2014 - 01/2013
3	Neoplasm Micrometastasis 01/2010 - 01/2005
2	Diverticulitis 01/2018 - 01/2017
2	Melanoma (Melanoma, Malignant) 07/2008 - 03/2008
1	Rectal Neoplasms (Rectal Cancer) 01/2019
1	Adenoma (Adenomas) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Morbid Obesity 01/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017
1	Lymphatic Metastasis 12/2012
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2012
1	Aneuploidy (Aneuploid) 10/2012
1	Human Influenza (Influenza) 03/2008
1	Genomic Instability 12/2004

Drug/Important Bio-Agent (IBA)

4	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 01/2017 - 12/2003
4	Coloring Agents (Dyes)IBA 10/2015 - 12/2003
3	Nucleic AcidsIBA 01/2021 - 10/2012
3	Monoclonal AntibodiesIBA 02/2014 - 12/2002
2	ProcalcitoninIBA 01/2018 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2017
2	Keratin-19 (Keratin 19)IBA 01/2017 - 12/2012
2	Keratins (Keratin)IBA 01/2017 - 06/2007
2	CarbonIBA 10/2015 - 03/2006
2	ParaffinIBA 12/2002 - 10/2002
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 06/2014
1	AntibodiesIBA 06/2014
1	Macrophage Colony-Stimulating FactorIBA 06/2014
1	CytokinesIBA 06/2014
1	LigandsIBA 06/2013
1	Peroxidase (Myeloperoxidase)IBA 01/2013
1	Messenger RNA (mRNA)IBA 12/2012
1	Hematoxylin (Haematoxylon)IBA 12/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2012
1	Biological ProductsIBA 10/2012
1	Cytidine Monophosphate (CMP)IBA 10/2012
1	Differentiation AntigensIBA 03/2008
1	EpitopesIBA 03/2008
1	VirosomesIBA 03/2008
1	CD40 Ligand (CD40L)IBA 03/2008
1	Indicators and Reagents (Reagents)IBA 12/2004
1	Epithelial Cell Adhesion MoleculeIBA 08/2004
1	Keratin-17 (Keratin 17)IBA 12/2002
1	Keratin-5 (Keratin 5)IBA 12/2002
1	HoloenzymesIBA 10/2002
1	RNA (Ribonucleic Acid)IBA 10/2002
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2002
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2002
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2002

Therapy/Procedure

8	Therapeutics 10/2019 - 01/2005
6	Lymph Node Excision (Lymph Node Dissection) 06/2013 - 01/2005
2	Neoadjuvant Therapy 01/2019 - 10/2012
2	Adjuvant Chemotherapy 05/2017 - 03/2009
2	Immunotherapy 07/2008 - 03/2008
1	Colonic Pouches (S Pouch) 10/2019
1	Bariatric Surgery 01/2018
1	Drug Therapy (Chemotherapy) 10/2012